picture of

Merck expands distribution agreement with Roche

Merck to be the exclusive supplier of novel enzymes for polymerase chain reaction (PCR) and quantitative real-time PCR, for all countries except the US, Brazil and Japan

Recommended

Subscribers

Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +

New

Merck opens production facility exclusively for meglumine

January 18, 2017

The facility in Spain produces only the FDA-approved excipient meglumine, ensuring continuous s ...

Ingredients | Europe | Manufacturing and Equipment

Prima BioMed announces new product candidate IMP761: a LAG-3 agonist antibody

January 9, 2017

Prima BioMed announces that it has developed a new early stage product candidate, a humanised I ...

Ingredients | R and D

Inorganics spark rise in pharmaceutical innovation

January 17, 2017

Latest Clarivate Analytics analysis finds patents for inorganics have more than tripled

Ingredients

Auspherix provides update on its new class of organogold antibiotics

January 6, 2017

Auspherix Limited, the anti-infectives company meeting the urgent need for new antibiotics by d ...

Ingredients | R and D

Can epi-drugs capture the next wave of growth?

December 19, 2016

An explosion in the field of epigenetics has revealed multiple ‘goldmines’ in the form of biolo ...

Ingredients | Biotechnology | Measurement and Analysis

Tiziana Life Sciences in-licenses NI-1201, a fully human anti-IL-6R monoclonal antibody

January 3, 2017

Exclusive worldwide license expands therapeutic pipeline in key immunological areas

Ingredients | R and D | Finance

Optimising scale-up with flow process technologies

December 5, 2016

Speed of synthesis is of the essence when medicinal chemists invent new molecules, reports Sara ...

Ingredients | R and D | Manufacturing and Equipment

Abzena signs licence agreement with Trieza

December 22, 2016

Licence agreement for Composite Human Antibody technology

Ingredients | North America | Finance

The future of uniquely delivered drugs and ADCs

December 5, 2016

Kruthika Dhar of That’s Nice reports on unique delivery drugs and the marketplace

Ingredients | R and D

Symcel and Colzyx partner to test 25 novel, first-in-kind collagen VI-derived antimicrobial peptides with calScreener

December 20, 2016

The first time ever peptides of this nature are tested for effectiveness in combating microbial ...

Ingredients | R and D | Measurement and Analysis

Potent oral solid dosage APIs: containment fundamentals

November 17, 2016

The last 20 years have seen a significant increase in the need for contained handling and proce ...

Containment | Ingredients | Regulatory | Manufacturing and Equipment

In Brief